Items where authors include "Pantano, F."

Article

Puppo, M., Croset, M., Ceresa, D. et al. (7 more authors) (2024) Protective effects of miR-24-2-5p in early stages of breast cancer bone metastasis. Breast Cancer Research, 26. 186. ISSN 1465-5411

Puppo, M. orcid.org/0000-0003-1409-9577, Valluru, M.K. orcid.org/0000-0001-9156-866X, Croset, M. et al. (9 more authors) (2023) MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness. British Journal of Cancer, 129 (5). pp. 754-771. ISSN 0007-0920

Pantano, F., Croset, M., Driouch, K. et al. (15 more authors) (2021) Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions. Oncogene, 40 (7). pp. 1284-1299. ISSN 0950-9232

Vargas, G., Bouchet, M., Bouazza, L. et al. (22 more authors) (2019) ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors. Oncogene, 38 (7). pp. 950-964. ISSN 0950-9232

Croset, M., Pantano, F., Kan, C.W.S. et al. (10 more authors) (2018) miRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis–associated genes. Cancer Research, 78 (18). pp. 5259-5273. ISSN 0008-5472

Fradet, A., Bouchet, M., Delliaux, C. et al. (17 more authors) (2016) Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in bone. Oncotarget, 7 (47). pp. 77071-77086.

Block, K.I., Gyllenhaal, C., Lowe, L. et al. (177 more authors) (2015) Designing a broad-spectrum integrative approach for cancer prevention and treatment. Seminars in Cancer Biology, 35. S276-S304. ISSN 1044-579X

Santini, D., Schiavon, G., Vincenzi, B. et al. (16 more authors) (2011) Receptor activator of NF-kB (RANK) expression in primary tumors associates with bone metastasis occurrence in breast cancer patients. PLoS ONE, 6 (4). e19234.